Related Experiment Video
Updated: Jun 12, 2026
09:07
Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
Published on: December 23, 2022
Lafora disease: epidemiology, pathophysiology and management
Thomas S Monaghan1, Norman Delanty
1Department of Neurology and Neuroscience, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin 9, Ireland.
CNS Drugs
|June 10, 2010
Summary
Lafora disease is a rare, fatal epilepsy linked to carbohydrate metabolism issues. Understanding its genetic basis offers hope for future treatments beyond current symptomatic management.
Area of Science:
- Neuroscience
- Genetics
- Metabolic Disorders
Background:
- Lafora disease is a rare, fatal, autosomal recessive progressive myoclonic epilepsy.
- It involves polyglucosan inclusion bodies in neural and other tissues, stemming from laforin or malin protein abnormalities.
- Characterized by epilepsy, myoclonus, and dementia.
Purpose of the Study:
- To summarize the current understanding of Lafora disease.
- To highlight diagnostic challenges and current therapeutic limitations.
- To emphasize the potential for future therapies based on pathophysiological insights.
Main Methods:
- Review of existing literature on Lafora disease.
- Analysis of diagnostic findings from MRI and neurophysiological tests.
- Consideration of genetic studies and biopsy in diagnosis.
Main Results:
- Diagnostic findings on MRI and neurophysiological testing are not definitive.
- Biopsy or genetic studies may be required for accurate diagnosis.
- Current therapy is limited to symptomatic management.
Conclusions:
- Lafora disease is a complex neurological and metabolic disorder.
- Accurate diagnosis may require advanced genetic or tissue analysis.
- Further research into pathophysiology offers hope for novel therapeutic strategies.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:17Introduction to Language of Pathophysiology ll
This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...